TF Market Research



Title:

COMMERCIAL INSIGHT: MIGRAINE

Price:$14,800.00
Publication Date:Dec 28, 2007
Source:DATAMONITOR PREMIUM REPORTS
Brief Excerpt:...With the seven triptan brands continuing to dominate acute migraine treatment and Ortho- McNeil s Topamax (topiramate) driving sales in the prophylactic market, seven major market revenues increased by #.#% from #### to $#.# billion in ####. The launch of pipeline drugs will only periodica lly offset genericization of GSK s Imitrex (sumatriptan) and Topamax. Further triptan genericization will dictate market dynamics through to ####. Nevertheless, the largely underserved prophylactic market and additional indications such as menstrual migraine will continue to present attractive opportunities to both current and future market players. Coverage: Seven major markets (US, France , Germany, Italy, Spain, UK, and Japan) ...
Length:187 Pages (185 Billable Pages)
Geographic Region:MULTINATIONAL
Industries:HEALTH CARE, MEDICAL SUPPLY, PHARMACEUTICALS
Non-Billable Page Numbers:186;187
Format:Adobe Acrobat Adobe Acrobat

Sections
TitleStarting PageNumber of Pages
Commercial Insight: Migraine11
ABOUT DATAMONITOR HEALTHCARE21
About the Migraine pharmaceutical analysis team21
CHAPTER 1 EXECUTIVE SUMMARY31
Objective of the analysis31
Datamonitor insight into the migraine market32
Market forecast summary51
Contributing experts51
Related reports61
CHAPTER 1 EXECUTIVE SUMMARY 371
CHAPTER 2 MARKET DEFINITION AND OVERVIEW 1671
CHAPTER 3 COUNTRY MARKET ASSESSMENTS 2673
CHAPTER 4 FORECAST ANALYSIS 89102
CHAPTER 5 COMMERCIAL IMPACT AND LIFECYCLE MANAGEMENT: CASE STUDIES 113122
BIBLIOGRAPHY 147141
APPENDIX A- MARKET DATA AND MAJOR BRAND KEY FACTS 160141
APPENDIX B- MARKET FORECAST DATA 175141
APPENDIX C 184151
CHAPTER 2 MARKET DEFINITION AND OVERVIEW161
Market definition for this report161
Current market situation178
Strategic scoping and focus251
CHAPTER 3 COUNTRY MARKET ASSESSMENTS261
Summary of environmental issues affecting migraine market size262
Seven major market opportunities and threats2822
US: opportunities and threats509
Japan: opportunities and threats594
France: opportunities and threats636
Germany: opportunities and threats695
Italy: opportunities and threats743
Spain: opportunities and threats773
UK: opportunities and threats809
CHAPTER 4 FORECAST ANALYSIS891
Key events8921
Data definitions, limitations and assumptions1102
Forecasts1121
Forecast methodology1121
CHAPTER 5 COMMERCIAL IMPACT AND LIFECYCLE MANAGEMENT: CASE STUDIES1131
Introduction1131
Portfolio management strategies to increase revenue and offset triptan genericization11314
Significant opportunity remains in the largely underserved prophylactic market12710
Menstrual migraine represents an unknown yet potentially attractive niche market13710
BIBLIOGRAPHY1471
Journal papers1475
Websites1527
Newspaper articles1591
Datamonitor reports1591
APPENDIX A- MARKET DATA AND MAJOR BRAND KEY FACTS1601
ATC classes included in 'others' to define the migraine market1602
Menstrual migraine market sizing calculations1623
Summary migraine market data1651
Triptan market data1667
Anticonvulsant market data1732
APPENDIX B-MARKET FORECAST DATA1751
Seven major markets1751
5EU market forecasts1761
US market forecasts1771
Japan market forecasts1781
France market forecasts1791
Germany market forecasts1801
Italy market forecasts1811
Spain market forecasts1821
UK market forecasts1831
APPENDIX C1841
Contributing experts1841
Report methodology1851
About Datamonitor1853
Tables
TitleStarting PageNumber of Pages
OF CONTENTS71

Enter the keyword(s) which you would like to search for within this document and click "Search"

 
Purchase Report
Price: $14,800.00

Looking For Something Else?





TF Market Research

TF Market Research® reports contain in-depth primary research and statistics, market trends, forecasts, segment analysis and much more from over 100 top consulting, market research and business publishing sources. The service is updated daily.

  about us | contact us | public company index | private company index | pcan | widget | your privacy rights | terms & conditions  

Copyright © 2008 Alacra, Inc., 100 Broadway, Suite 1100, New York, NY 10005. All rights reserved.
Reproduction in whole or in part in any form or medium without express written permission is prohibited.